NCT01004224 - A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies | Biotech Hunter

Enrollment

208

Participants

Timeline

Start Date

December 11, 2009

Primary Completion Date

October 8, 2018

Study Completion Date

October 8, 2018

Conditions

Advanced Solid Tumors With Alterations of FGFR1, 2 and or 3Squamous Lung Cancer With FGFR1 AmplificationBladder Cancer With FGFR3 Mutation or FusionAdvanced Solid Tumors With FGFR1 AmplicationAdvanced Solid Tumors With FGFR2 AmplicationAdvanced Solid Tumors With FGFR3 Mutation

Interventions

DRUG

BGJ398

Trial Locations (50)

3084

Novartis Investigative Site, Heidelberg

10021

Memorial Sloan Kettering Cancer Center Onc. Dept.., New York

10029

Novartis Investigative Site, New York

10048

Novartis Investigative Site, Taipei

10330

Novartis Investigative Site, Bangkok

13273

Novartis Investigative Site, Marseille

15232

Novartis Investigative Site, Pittsburgh

19104

Novartis Investigative Site, Philadelphia

28009

Novartis Investigative Site, Madrid

28041

Novartis Investigative Site, Madrid

28050

Novartis Investigative Site, Madrid

30625

Novartis Investigative Site, Hanover

31059

Novartis Investigative Site, Toulouse

33075

Novartis Investigative Site, Bordeaux

34298

Novartis Investigative Site, Montpellier

35039

Novartis Investigative Site, Marburg

35040

Novartis Investigative Site, Izmir

37203

Novartis Investigative Site, Nashville

38120

Novartis Investigative Site, Memphis

41013

Novartis Investigative Site, Seville

43221

Novartis Investigative Site, Columbus

44805

Novartis Investigative Site, Saint-Herblain Cédex

45147

Novartis Investigative Site, Essen

46009

Novartis Investigative Site, Valencia

47014

Novartis Investigative Site, Meldola

48201

Novartis Investigative Site, Detroit

50200

Novartis Investigative Site, Chiang Mai

50937

Novartis Investigative Site, Cologne

69373

Novartis Investigative Site, Lyon

75015

Novartis Investigative Site, Paris

80045

University of Colorado Dept. of Anschutz Cancer (3), Aurora

84103

Novartis Investigative Site, Salt Lake City

90033

Novartis Investigative Site, Los Angeles

90095

Novartis Investigative Site, Los Angeles

92150

Novartis Investigative Site, Suresnes

94805

Novartis Investigative Site, Villejuif

169610

Novartis Investigative Site, Singapore

5265601

Novartis Investigative Site, Ramat Gan

6423906

Novartis Investigative Site, Tel Aviv

91010 3000

Novartis Investigative Site, Duarte

06520

Novartis Investigative Site, New Haven

02114

Novartis Investigative Site, Boston

19107-5098

Thomas Jefferson University Hospital Onc Dept, Philadelphia

A-1100

Novartis Investigative Site, Vienna

1066 CX

Novartis Investigative Site, Amsterdam

1081 HV

Novartis Investigative Site, Amsterdam

05505

Novartis Investigative Site, Seoul

03080

Novartis Investigative Site, Seoul

08035

Novartis Investigative Site, Barcelona

08041

Novartis Investigative Site, Barcelona